New Therapeutic Target for Myeloproliferative Neoplasm
MPN— myeloproliferative neoplasm—involves the production of too many red blood cells, white blood cells, or platelets in the body.
Hydroxyurea Therapy Found Effective for Myeloproliferative Neoplasms
Patients with myeloproliferative neoplasms (MPN) with essential thrombocythemia (ET) or polycythemia vera (PV) were found to benefit from hydroxyurea therapy.
Males with MPN Have Inferior Survival Compared to Females
Males with myeloproliferative neoplasms (MPN) were found to have inferior survival compared to females in a well-defined, prospective, observational cohort.
Daily Smokers Have a More than 3 Times Increased Risk for MPN
Investigators in Denmark found that both current and ex-smokers have an increased risk of developing myeloproliferative neoplasms.
Young Myeloproliferative Neoplasms Patients Have Longer Survival than Older Counterparts
Mayo Clinic investigators found young patients with myeloproliferative neoplasms who are under age 40 are a steadily growing population and seem to have longer survival than their older counterparts.
Using Interferon‐α2 & Ruxolitinib Combination Therapy to Treat Myeloproliferative Neoplasms
Interferon‐α2 and ruxolitinib combination therapy shows promise in treating myeloproliferative neoplasms, according to recent preliminary findings.
Myeloproliferative Neoplasms Impair Patient Employment Status & Work Productivity
Investigators have found
that the higher the symptom burden, the greater the detrimental impact on work productivity and daily activity for patients with myeloproliferative neoplasms.
Gene Found to Enable Deadly Myelodysplastic Syndromes
Investigators in Cincinnati have linked a gene with myelodysplastic syndromes, potentially offering the first step toward a new genetic therapy.
Understanding Genetics to Develop Future Treatments for Rare Cancers
Pauline Funchain MD, explains how better understanding of genetics can help shape future treatments for rare cancers.
Relatives of Patients with Myeloid Blood Cancer at Two-Fold Risk of Disease
Relatives of individuals with certain types of blood cancer may harbor inherited genetic changes that could influence their risk of developing diseases that arise from myeloid cells.
Next Page >>
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2019 Rare Disease Communications. All Rights Reserved.